Register Now: From Clinical to Commercial: Accelerating ADC Late-Stage Development with Technology Innovation and Integrated Platform
|Articles|September 27, 2013

West Pharmaceutical Opens Second Manufacturing Plant in China

West Pharmaceutical Services opens its second manufacturing plant in China to expand presence in Asian markets.

West Pharmaceutical Services, a provider of solutions for injectable-drug administration, started up its compression-molding plant in the Shanghai Zhangjiang High-Tech Industrial Development Zone Qingpu Park in China. The new plant is adjacent to West’s injection-molding facility that was dedicated in September 2009.

The 11,900-m2 compression-molding plant manufactures components used for packaging injectable drugs, supplying customers primarily in China and the Asia-Pacific region. Construction began in June 2011.

In addition to the plants in Qingpu, West’s presence in the Asia-Pacific region includes a factory in Singapore and sales offices in Australia, China, India and Singapore. The company’s first manufacturing facility in India is under construction.

Source: West Pharmaceutical Services


Related to this article

The BioPharm Brief: Cosentyx Approved in Polymyalgia Rheumatica, a Phase 3 Survival Win for an AML Vaccine, and $173 Million for In Vivo Bone Marrow Editing
FDA approves Novartis’ Cosentyx as the first anti-IL-17 biologic for polymyalgia rheumatica, SELLAS Life Sciences’ WT1-targeted peptide vaccine galinpepimut-S meets its overall survival primary endpoint in the phase 3 REGAL trial in AML, and Marrow Therapeutics launches with $173 million to develop bone marrow-targeted genetic medicines.